XBB.1.5 RBD-Based Bivalent Vaccines Induced Antibody Responses Against SARS-CoV-2 Variants in Mice

XBB.1.5 RBD-Based Bivalent Vaccines Induced Antibody Responses Against SARS-CoV-2 Variants in Mice

(1) Background: The currently circulating variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits resistance to antibodies induced by vaccines. The World Health Organization recommended the use of monovalent XBB.1 sublineages (e.g., XBB.1.5) as an antigenic component in 2023...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiawen Liu, Tiantian Wang, Hongying Ren, Ruixi Liu, Qian Wang, Jun Wu, Bo Liu
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Vaccines
Subjects:
SARS-CoV-2
RBD
subunit vaccine
monovalent vaccine
bivalent vaccine
glycoengineered yeast
Online Access:https://www.mdpi.com/2076-393X/13/5/543
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items